SOURCE: RoboticOncology.com

Prostate Cancer - http://www.RoboticOncology.com

April 28, 2010 16:50 ET

RoboticOncology.com: With Over 3,000 Successful Surgeries Under His Belt, Dr. David B. Samadi, MD Hits Home Runs When It Comes to Prostate Cancer Cure

The Trifecta Significance in Prostate Cancer Treatment

NEW YORK, NY--(Marketwire - April 28, 2010) -  Long considered a mystical number, Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, has incorporated this number in his robotic prostatectomy practice. With over 3,000 successful prostate cancer treatments to his credit, Samadi's experience is unequaled. He completed surgical fellowships in robotics, open and laparoscopic surgery. Samadi considers himself "three surgeons in one head," which is absolutely vital in surgery, if ever he were to have to switch from one type of prostate surgery to another.

Dr. Samadi uses a three-pronged approach when deciding on a prostate cancer treatment plan for his patients. He factors their prostate specific antigen (PSA) level, digital rectal exam (DRE) and Gleason scores. Along with other risk factors such as lifestyle and family history, this information is used as a baseline monitor to help Dr. Samadi successfully treat this disease.

The most popular treatment options currently for prostate cancer are radiation, active surveillance and prostatectomy. Radiation involves the use of high-energy rays or seeds to destroy cancer cells. It is best for recurrent cancer cases as well as low-grade, prostate-confined cancer. Active surveillance, or "watchful waiting," entails waiting until there are symptoms before starting treatment. In some cases, it means closely monitoring the patient's tests, exams and ultrasounds to determine the rate of cancer growth. The third option is removing the entire prostate gland via a radical prostatectomy, done traditionally (open surgery), laparoscopically, or robotically.

Understandably, in choosing treatment, Dr. Samadi stands behind a radical prostatectomy, as the "gold standard" for completely eliminating prostate cancer that is organ-confined. He believes that the robotic prostatectomy, with the da Vinci robot, is the most thorough way of treating prostate cancer. "In removing the prostate, it's the best way I can determine three things: the type of cancer, the stage of the cancer and if the cancer is organ-contained," he explained.

As part of his "triple play philosophy," Dr. Samadi firmly believes that with his background with open prostate surgery and laparoscopic prostatectomy, robotic prostate surgery can give patients the best possibility of a cure. Post-operative long-term PSA levels are undetectable; patients retain their sexual function and continence (see charts). "These factors are very important to my patients, and what I've seen with robotic surgery is that these factors have been consistently provided to them," continued Samadi.

"Choosing robotic surgery should be an easy decision because of its many advantages. Choosing the right surgeon is the most important factor, as patients should go with surgeons who perform many cases and have a background in oncology as well as other types surgeries," says Dr. Samadi, "With robotics, surgeons have more magnification, visibility and range of motion with no tremors. There are smaller incisions with minimal blood loss. Surgery time is just 1-2 hours. Patients are discharged from the hospital within 24 hours. Recovery is quicker and side effects are drastically reduced." Samadi is sure that his trifecta approach to prostate cancer and robotic surgery is the most effective treatment option for prostate cancer patients.

Contact Information